Promising News on Stem Cells

Published Online: Friday, November 1, 2002

In the future, type 1 diabetes patients may be able to avoid the need for daily insulin shots through transplants of insulin-producing stem cells. ?We have done 38 islet cell transplant procedures since 1999,? said Dr. Jonathan Lakey of the University of Alberta in Edmonton. ?And 87% of those patients are free of insulin therapy a year after transplantation.? (The islets of Langerhans are the insulin-making parts of the pancreas.)
The news is especially exciting because there is an acute shortage of transplantable pancreases worldwide. Stem cell therapy also reduces or eliminates transplant rejections. More work is necessary, however, including satisfying the concerns of those who object to using stem cells on ethical grounds.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues